Profile

Nilamadhab Mishra, M.D.Wake Forest Baptist Health

Doctor Rating

4 out of 5

163 Ratings
15 Comments
 

Nilamadhab Mishra, M.D.

Associate Professor,


Clinical Interests

Rheumatoid Arthritis, Sjogren's Syndrome, Systemic Lupus Erythematosus

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-4209
Department: 336-716-4209

Insurance Accepted »

Education & Training

  • B.Sc., Free Standing Institute-India, 1983
  • M.B.,B.S., M.K.C.G. Medical College, Berhampur, Orissa, 1989
  • Fellowship, Delhi University College Medic, 1996
  • Fellowship, WFU School of Medicine, 2001

NPI Number

  • 1104801232
Nilamadhab Mishra, M.D.

Doctor Rating

4 out of 5

163 Ratings
15 Comments
 

Nilamadhab Mishra, M.D.

Associate Professor, Rheumatology and Immunology
Comprehensive Cancer Center
Physiology & Pharmacology

Research Interests

immunology/allergy/inflammatio

Contact Information

Academic: 336-716-4209 | Department: 336-716-4209

Recent Publications

Cao Q, Rong S, Repa JJ, Clair RS, Parks JS, Mishra N. Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development. Arterioscler Thromb Vasc Biol. 2014;34(9):1871-1879.

Sridharan R, Gonzales-Cope M, Chronis C, Bonora G, McKee R, Huang C, Patel S, Lopez D, Mishra N, Pellegrini M, Carey M, Garcia BA, Plath K. Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1 gamma in reprogramming to pluripotency. Nat Cell Biol. 2013;15(7):872-882.

Rong S, Cao Q, Liu M, Seo J, Jia L, Boudyguina E, Gebre AK, Colvin PL, Smith TL, Murphy RC, Mishra N, Parks JS. Macrophage 12/15 lipoxygenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis. J Lipid Res. 2012;53(4):686-695.

Reilly CM, Regna N, Mishra N. HDAC inhibition in lupus models. Mol Med. 2011;17(5-6):417-425.

Yan K, Cao Q, Reilly CM, Young NL, Garcia BA, Mishra N. Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity. J Biol Chem. 2011;286(33):28833-43.

Burger KL, Davis AL, Isom S, Mishra N, Seals DF. The podosome marker protein Tks5 regulates macrophage invasive behavior. Cytoskeleton (Hoboken). 2011;68(12):694-711.

Hodges SJ, Yoo JJ, Mishra N, Atala A. The effect of epigenetic therapy on congenital neurogenic bladders--a pilot study. Urology. 2010;75(4):868-872.

Vachharajani V, Wang SW, Mishra N, El Gazzar M, Yoza B, McCall C. Curcumin modulates leukocyte and platelet adhesion in murine sepsis. Microcirculation. 2010;17(6):407-416.

Kalin Y, Qiang C, Reilly CM, Cann JA, Rhonda BD, Olson EN, Garcia B, Mishra NA. An epigenetic switch involving chromatin modifier HDAC9 in T cells links to lupus pathogenesis in MRL/Ipr mice [abstract]. J Dermatol. 2010;37(Suppl 1):35.

Mehta J, Genin A, Brunner M, Scalzi LV, Mishra N, Beukelman T, Cron RQ. Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis. Arthritis Rheum. 2010;62(8):2499-2509.

Furie R, Stohl W, Ginzler EM, Becker M, Mishra N, Chatham W, Merrill JT, Weinstein A, McCune WJ, Zhong J, et al. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res Ther. 2009;10(5):art. R109.

Burger KL, Mishra N, Seals D. Tks5 and macrophage podosome formation [abstract]. Clin Exp Metastasis. 2009;26(7):869.

Mishra N, Hammer G, inventors; Wake Forest University Health Sciences, assignee. Method of treating immune diseases. United States patent US 7,557,141. 2009 July 7. 2009;():.

Lu X, Kovalev GI, Chang H, Kallin E, Knudsen G, Xia L, Mishra N, Ruiz P, Li E, Su L, Zhang Y. Inactivation of NuRD component Mta2 causes abnormal T cell activation and lupus-like autoimmune disease in mice. J Biol Chem. 2008;283(20):13825-33.

Zhu X, Lee J-Y, Timmins JM, Brown JM, Boudyguina E, Mulya A, Gebre AK, Willingham MC, Mishra N, Parks JS, et al. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem. 2008;283(34):22930-41.

Sodhi R, Mishra N. Selective toll-like receptor agonist combinations synergistically trigger inflammatory mediators in macrophages, which can be inhibited by histone deacetylase inhibition [abstract]. Arthritis Rheum. 2008;58(9 Suppl):S185.

Reilly CM, Thomas M, Gogal R Jr, Olgun S, Santo A, Sodhi R, Samy ET, Peng SL, Gilkeson GS, Mishra N. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. J Autoimmun. 2008;31(2):123-130.

Garcia BA, Hake SB, Diaz RL, Kauer M, Morris SA, Recht J, Shabanowitz J, Mishra N, Strahl BD, Allis CD, Hunt DF. Organismal differences in post-translational modifications in histones H3 and H4. J Biol Chem. 2007;282(10):7641-7655.

Kammer GD, Mishra N, inventors; Wake Forest University Health Sciences, assignee. Method of treating autoimmune disease. United States patent US 7,271,198. 2007 Sept 18. 2007;():.

Atwood T, Carter C, Zhu JM, Mishra N. Monitoring neuropsychiatric symptoms in Mrl/lpr lupus mouse model with proton magnetic resonance spectroscope [abstract]. Arthritis Rheum. 2006;54(9):S622.

Mishra N, Keiger K, Labourier E. MicroRNA signature in human lupus [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S753.

Mishra N, Keiger K, Labourier E. Microrna, innate immunity and lupus [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S39.

Mishra N, Parks J, Rankin C, Clair R. Histone deacetylase inhibitors decrease macrophage foam cell formation and stabilize atherosclerotic plaques by multiple mechanisms [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S580.

Snowhite I, Mishra N. Histone hypermethylation is an indicator of epigenetic plasticity in activated B lymphocytes [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S41.

Snowhite I, Mishra N. Histone hypermethylation is an indicator of epigenetic plasticity in activated B lymphocytes [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S69.

Sodhi R, Mishra N. Selective toll-like receptor agonist combinations synergistically trigger inflammatory mediators in macrophages, which can be inhibited by histone deacetylase inhibition [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S43.

Sodhi R, Mishra N. Selective toll-like receptor agonist combinations synergistically trigger inflammatory mediators in macrophages, which can be inhibited by histone deacetylase inhibition [abstract]. Arthritis Rheum. 2006;54(9 Suppl):S635.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Rheumatology and Immunology

Clinical Interests

Rheumatoid Arthritis, Sjogren's Syndrome, Systemic Lupus Erythematosus
Nilamadhab Mishra, M.D.

Nilamadhab Mishra, M.D.

Associate Professor, Rheumatology and Immunology
Comprehensive Cancer Center
Physiology & Pharmacology

Doctor Rating

4 out of 5

Nilamadhab Mishra, M.D.163 Ratings
15 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
3.9
CP efforts to include in decisions
4
CP explanations of prob/condition
3.9
CP spoke using clear language
4
Friendliness/courtesy of CP
4.4
Likelihood of recommending CP
3.8
Patients' confidence in CP
3.9
Time CP spent with patient
4
Wait time at clinic
4.1



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

12/15/2015

I feel very blessed that someone recommended Dr. Mishra to me. I went for quite some time in pain and not truly understanding my condition. He and his staff have been so polite and kind and I trust their knowledge.

11/16/2015

It was a first visit. I felt rushed through the visit, however I understand that test results taken during the visit are needed to have a more thorough discussion about my problems.

11/9/2015

Dr. M is a great rheumatologist and makes visits as easy as possible.

10/28/2015

Dr was very polite, caring and understand. He explained everything very well.

10/21/2015

Very good care.

9/7/2015

he completely dismissed my concerns without even a discussion or thorough exam. he even went as far as suggesting that the condition my mother has lived with for 30 years was not real -- and he's never met her. I'll never go back.

8/21/2015

Experience is good.

8/9/2015

Excellent care. Very thorough. Answered all of my questions. Really appreciated Dr. Mishra's time.

8/8/2015

I needed to know more about Vasculitis, and what to avoid, etc., would be helpful.

7/27/2015

took over two weeks to get an appointment when in severe pain. At the appointment I felt as if the doctor didn't really listen to me or didn't understand my concerns (or didn't care).

3/25/2015

I had an excellent experience with Dr. Mishra and his office staff. He is the first doctor to take time and listen to me since I have been sick and I am so grateful. He ordered many labs for me to check for all my symptoms. I have received my lab results but have not scheduled a follow up or anything as of yet. Overall he has helped me more than he will probably ever realize and I am so thankful. Also the office staff from registration all the way to the lab staff that saw me for blood work were so pleasant and kind. Thank you all so much.

3/23/2015

*Dr. Mishra is a very good doctor!

2/24/2015

After getting the results in professional jargon that I didn't understand, I e-mailed Dr Mishra and he promptly replied in terms I could understand.

2/17/2015

*Dr. Mishra repeats my questions/concerns back to me but never actually answers them.

2/11/2015

I have only seen this care provider for 3 visits and it is also the first time using Wake Med as a provider. I have been extremely pleased with the care I have received. Dr. Mishra has help me more in 3 visits than my former provider( not associated with this facility) did in 12 months. I have great trust in Dr. Mishra and am looking forward better health.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.